Contact
searchSearch
HMP Global

Volume 18 - Issue 1 - January, 2006

Feature

Case Report
One Year Follow-Up of Sirolimus-Eluting Stent in a Cardiac
Post-Transplant Patient
08/01/2008
Thomas A. Hennebry, MB, BCh, BAO, MD; Abdul Rashid, MD; Jorge Saucedo, MD
Case Report. A 57-year-old woman underwent orthotopic cardiac transplant in 1997 secondary to nonischemic cardiomyopathy. Her symptoms of heart failure started in 1993 after a week of flu-like illness. A year later, she was diagnosed with...
Case Report. A 57-year-old woman underwent orthotopic cardiac transplant in 1997 secondary to nonischemic cardiomyopathy. Her symptoms of heart failure started in 1993 after a week of flu-like illness. A year later, she was diagnosed with...
Case Report. A 57-year-old woman...
08/01/2008
Journal of Invasive Cardiology
Case Report
Double-Catheter Technique for Catheterization of the Left Coronary Artery in a Patient with an Ascending Aorta Aneurysm
08/01/2008
David Zemanek, MD, PhD; Josef Veselka, MD, PhD, FESC, FSCAI
Aneurysms of the ascending aorta are not uncommon in the catheterization laboratory. When encountered, they lead to problems catheterizing the left coronary artery in particular. We typically use catheters with a large bend in these cases...
Aneurysms of the ascending aorta are not uncommon in the catheterization laboratory. When encountered, they lead to problems catheterizing the left coronary artery in particular. We typically use catheters with a large bend in these cases...
Aneurysms of the ascending aorta...
08/01/2008
Journal of Invasive Cardiology
Case Report
Acute Coronary Occlusion and Myocardial Infarction Secondary to Blunt Chest Trauma from an Automobile Airbag Deployment
08/01/2008
Alan Zajarias, MD; Srihari Thanigaraj, MD; Megumi Taniuchi, MD, PhD
Non-penetrating thoracic trauma has been associated with multiple structural and electrical cardiac injuries and complications with a mortality rate of up to 15%.1 The mechanisms for non-penetrating cardiac injury include: direct trauma,...
Non-penetrating thoracic trauma has been associated with multiple structural and electrical cardiac injuries and complications with a mortality rate of up to 15%.1 The mechanisms for non-penetrating cardiac injury include: direct trauma,...
Non-penetrating thoracic trauma...
08/01/2008
Journal of Invasive Cardiology
Case Report
Coronary Artery Aneurysm following Drug-Eluting Stent Implantation
08/01/2008
S. Anandaraja, MD, DM; Kewal Krishan Talwar, MD, DM; Nitish Naik, MD
Percutaneous coronary interventions (PCI) are uncommon causes of coronary artery aneurysms (CAA). The incidence of CAA after percutaneous transluminal coronary angioplasty (PTCA) ranges from 3.9–5%,1,2,5–7 and after directional coronary...
Percutaneous coronary interventions (PCI) are uncommon causes of coronary artery aneurysms (CAA). The incidence of CAA after percutaneous transluminal coronary angioplasty (PTCA) ranges from 3.9–5%,1,2,5–7 and after directional coronary...
Percutaneous coronary...
08/01/2008
Journal of Invasive Cardiology
IAGS (International Andreas Gruentzig Society) Proceedings
Percutaneous Abdominal Aortic Disease Management: Long-Term Results (IAGS 2004)
08/01/2008
Michael L. Marin, MD; Eberhard Zeitler, MD; Klemens Barth, MD; Michael Lawrence-Brown, MD; Ernst Schneider, MD; Wolfgang Ritter, MD; Andrew Cragg, MD; Douglas M. Cavaye, MD
Wolfgang Ritter: We know that all devices have problems; for example, the VanGuard or the AneuRx® (Medtonic, Inc., Sunnyvale, California) can incur some disintegration 4 to 5 years postimplantation. With the Zenith device, the problem of late...
Wolfgang Ritter: We know that all devices have problems; for example, the VanGuard or the AneuRx® (Medtonic, Inc., Sunnyvale, California) can incur some disintegration 4 to 5 years postimplantation. With the Zenith device, the problem of late...
Wolfgang Ritter: We know that...
08/01/2008
Journal of Invasive Cardiology
IAGS (International Andreas Gruentzig Society) Proceedings
Industry Round Table: Where Are the New Drugs? (IAGS 2004)
08/01/2008
Scott Byrd; Philip Reid; John David Spencer, MD; Renato DeRita, MS; Mike Cowley, MD
Philip Reid (Eli Lilly & Company): Speaking as a cardiologist, not as a neurologist, I find that the challenge with the trial that Renato has just described is to demonstrate the efficacy of abciximab in acute nonhemorrhagic stroke patients....
Philip Reid (Eli Lilly & Company): Speaking as a cardiologist, not as a neurologist, I find that the challenge with the trial that Renato has just described is to demonstrate the efficacy of abciximab in acute nonhemorrhagic stroke patients....
Philip Reid (Eli Lilly &...
08/01/2008
Journal of Invasive Cardiology
Clinical Images
Myocardial Staining during Left Ventriculography with a Pigtail Catheter
08/01/2008
Cesar Moris, MD, PhD; Maria Martin, MD, PhD; Iñigo Lozano Martinez-Luengas, MD, PhD, FESC
The pigtail is the preferred catheter for left ventriculography. Because of its end-hole, which allows its manipulation with a guidewire, it can be advanced to the left ventricle both by the femoral and brachial approaches. The design of the...
The pigtail is the preferred catheter for left ventriculography. Because of its end-hole, which allows its manipulation with a guidewire, it can be advanced to the left ventricle both by the femoral and brachial approaches. The design of the...
The pigtail is the preferred...
08/01/2008
Journal of Invasive Cardiology

Column

Editorial Message
Jan-06
08/01/2008
Richard E. Shaw, PhD, FACC
Dear Readers, This issue of the Journal of Invasive Cardiology commences our 18th year of publication. There has been incredible growth in the field of invasive cardiology during 2005. Many of these growth areas have challenged the...
Dear Readers, This issue of the Journal of Invasive Cardiology commences our 18th year of publication. There has been incredible growth in the field of invasive cardiology during 2005. Many of these growth areas have challenged the...
Dear Readers, This issue of the...
08/01/2008
Journal of Invasive Cardiology
Arterial Remodeling Correlates Positively with Serological Evidence of Inflammation in Patients with Chronic Stable
Angina Pect
08/01/2008
Ian T. Meredith, BSc, PhD, MBBS, FRACP, MD; H.M. Omar Farouque, MBBS, PhD, MD; James D. Cameron, MBBS, MD, BE(Elec), MEngSci; Stephen G. Worthley, MBBS, PhD, MD, PhDH, MB, BS 
The development and even progression of coronary atherosclerotic lesions may occur without compromising the lumen in the early phases due to outward growth of the vessel wall; a concept known as “positive” or “outward” arterial remodeling.1...
The development and even progression of coronary atherosclerotic lesions may occur without compromising the lumen in the early phases due to outward growth of the vessel wall; a concept known as “positive” or “outward” arterial remodeling.1...
The development and even...
08/01/2008
Journal of Invasive Cardiology
Optimization of Myocardial Perfusion after Primary Coronary Angioplasty following an Acute Myocardial Infarction. Beyond TIMI 3
08/01/2008
Edo Kaluski, MD; Alberto Hendler, MD; Avi Aronovich, MD; Izhak Zyssman, MD; Yosef Gurevich, MD; Alex Blatt, MD; Meir Reicher, MD; Marina Leitman, MD; Istvan Czuriga, MD; Zvi Vered, MD; Ricardo Krakover, MD
Primary angioplasty has become the preferred therapeutic modality in patients with acute myocardial infarction (AMI). Despite a rapid and sustained restoration of flow through a previously occluded epicardial coronary artery, perfusion at the...
Primary angioplasty has become the preferred therapeutic modality in patients with acute myocardial infarction (AMI). Despite a rapid and sustained restoration of flow through a previously occluded epicardial coronary artery, perfusion at the...
Primary angioplasty has become...
08/01/2008
Journal of Invasive Cardiology

News

Intravascular Imaging
ECLIPSE Trial: Intravascular Imaging Can Improve Outcomes for Complex Stenting Procedures in Patients with High-Risk Calcified CAD
03/31/2025
“The ECLIPSE trial shows that use of intravascular imaging (IVI) to guide coronary stenting in severely calcified lesions prevents death, stent thrombosis, and unplanned repeat procedures in this high-risk patient population,” says first...
“The ECLIPSE trial shows that use of intravascular imaging (IVI) to guide coronary stenting in severely calcified lesions prevents death, stent thrombosis, and unplanned repeat procedures in this high-risk patient population,” says first...
“The ECLIPSE trial shows that...
03/31/2025
Cath Lab Digest
Aortic Stenosis
New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of Patients
03/31/2025
New data from DETECT AS and the EARLY TAVR Trial were presented at ACC.25 in Chicago, addressing the critical needs of patients with structural heart disease.
New data from DETECT AS and the EARLY TAVR Trial were presented at ACC.25 in Chicago, addressing the critical needs of patients with structural heart disease.
New data from DETECT AS and the...
03/31/2025
Cath Lab Digest
CAD in Women
New Intermountain Health Study Finds Gap Between Heart Disease Outcomes in Men and Women Has Narrowed Over Past 20 Years  
03/31/2025
Women studied tended to be older with more comorbidities (like high blood pressure, diabetes, and history of stroke and heart failure), have more stable chest pain, and experience less severe chest pain or heart attack when they came into the...
Women studied tended to be older with more comorbidities (like high blood pressure, diabetes, and history of stroke and heart failure), have more stable chest pain, and experience less severe chest pain or heart attack when they came into the...
Women studied tended to be older...
03/31/2025
Cath Lab Digest
AI
HeartFocus Clinical Trial Proves AI Can Empower Novices to Deliver Diagnostic-Quality Cardiac Ultrasounds
03/31/2025
Results showed that 100% of exams conducted by novices using HeartFocus met the diagnostic standards for all primary endpoints, with a strong correlation to expert-acquired scans across qualitative and quantitative assessments.
Results showed that 100% of exams conducted by novices using HeartFocus met the diagnostic standards for all primary endpoints, with a strong correlation to expert-acquired scans across qualitative and quantitative assessments.
Results showed that 100% of...
03/31/2025
Cath Lab Digest
plaque analysis
CONFIRM2 Registry: Late-Breaking Clinical Trial Results Demonstrate the Predictive Power of Cleerly's AI-QCT for Women’s Cardiovascular Risk at ACC.25
03/31/2025
The findings demonstrate that AI-QCT features of coronary artery disease (CAD), as detected by Cleerly’s AI-QCT, can identify women at high risk for major adverse cardiovascular events (MACE) and improves risk stratification - a population...
The findings demonstrate that AI-QCT features of coronary artery disease (CAD), as detected by Cleerly’s AI-QCT, can identify women at high risk for major adverse cardiovascular events (MACE) and improves risk stratification - a population...
The findings demonstrate that...
03/31/2025
Cath Lab Digest
Statins
CorCal Outcomes Study: Who Needs a Statin? Intermountain Study Compares Prescribing Recommendations Based on Traditional Risk Factors vs. Coronary Artery Calcium Scoring
03/31/2025
The research is part of CorCal Outcomes, a large, randomized clinical trial at Intermountain Health that is comparing the PCE versus CAC score guidance to initiate a statin prescription for patients for primary prevention of coronary heart...
The research is part of CorCal Outcomes, a large, randomized clinical trial at Intermountain Health that is comparing the PCE versus CAC score guidance to initiate a statin prescription for patients for primary prevention of coronary heart...
The research is part of CorCal...
03/31/2025
Cath Lab Digest
CardiAMP Procedure
Cell Therapy
BioCardia Phase 3 CARDIAMP-HF Trial of Novel Cardiac Cell Therapy for Ischemic Heart Failure Shows Increased Survival, Decreased Cardiac Events, and Improved Quality of Life at Two Years
03/31/2025
"In this rigorous CardiAMP-HF Trial, patients who received the novel cell therapy adjunctive to medication experienced decreased mortality and MACCE, with improved quality of life, when compared to those on medication alone," said...
"In this rigorous CardiAMP-HF Trial, patients who received the novel cell therapy adjunctive to medication experienced decreased mortality and MACCE, with improved quality of life, when compared to those on medication alone," said...
"In this rigorous CardiAMP-HF...
03/31/2025
Cath Lab Digest
Peripheral Arterial Disease
New Study Finds Peripheral Artery Disease Often Underdiagnosed and Undertreated; Opportunity to Improve Treatments and Lower Death Rates
03/31/2025
Researchers identified 7,522 patients who had a symptomatic peripheral artery disease diagnosis at Intermountain Health facilities between January 2006 and December 2021 and were seen once in follow-up within at least 18 months of their...
Researchers identified 7,522 patients who had a symptomatic peripheral artery disease diagnosis at Intermountain Health facilities between January 2006 and December 2021 and were seen once in follow-up within at least 18 months of their...
Researchers identified 7,522...
03/31/2025
Cath Lab Digest
TAVR
Evolut Low Risk Trial: Medtronic Evolut TAVR System Shows Durable Clinical Outcomes and Outstanding Valve Performance at 5 Years in Low-Risk AS Patients
03/31/2025
"Results at five years support Evolut's supra-annular, self-expanding TAVR as a safe, effective, and durable alternative to surgery for patients with severe aortic stenosis, regardless of their surgical risk," said Michael J. Reardon, MD.
"Results at five years support Evolut's supra-annular, self-expanding TAVR as a safe, effective, and durable alternative to surgery for patients with severe aortic stenosis, regardless of their surgical risk," said Michael J. Reardon, MD.
"Results at five years support...
03/31/2025
Cath Lab Digest
Calcium Score
Low Coronary Artery Calcium Score is Associated with An Excellent Prognosis Regardless of a Person’s Age, New Intermountain Health Study Finds
03/31/2025
“We found that a zero-plaque burden is not only highly prognostic of good heart health at any age, but also of excellent overall survival,” said Jeffrey L. Anderson, MD, principal investigator of the study.
“We found that a zero-plaque burden is not only highly prognostic of good heart health at any age, but also of excellent overall survival,” said Jeffrey L. Anderson, MD, principal investigator of the study.
“We found that a zero-plaque...
03/31/2025
Cath Lab Digest

CRT Conference Coverage
Disparities in Interventional Cardiology
04/02/2025
Laura Simson
At the Sunday afternoon "Disparities in Interventional Cardiology" session at CRT 2025, experts presented compelling data and discussed the barriers that limit diverse representation in the field, ranging from clinical trials and...
At the Sunday afternoon "Disparities in Interventional Cardiology" session at CRT 2025, experts presented compelling data and discussed the barriers that limit diverse representation in the field, ranging from clinical trials and...
At the Sunday afternoon...
04/02/2025
Journal of Invasive Cardiology
CRT Conference Coverage
Artificial Intelligence in Coronary Artery Disease Diagnosis and Intervention
04/02/2025
Laura Simson
In his Sunday morning session and ensuing panel discussion at CRT 2025, Dr Ran Kornowski of the Rabin Medical Center in Petach-Tikva, Israel, detailed how AI is transforming clinical practice and research in interventional cardiology.
In his Sunday morning session and ensuing panel discussion at CRT 2025, Dr Ran Kornowski of the Rabin Medical Center in Petach-Tikva, Israel, detailed how AI is transforming clinical practice and research in interventional cardiology.
In his Sunday morning session...
04/02/2025
Journal of Invasive Cardiology
Original Contribution
Polidocanol Ablation in Midventricular Obstructive Cardiomyopathy: Novel Approach and Early Outcomes
04/01/2025
Limited data exist regarding polidocanol use for septal ablation, particularly in the context of midventricular obstruction (MVO) . This study presents the first reported use of polidocanol for septal ablation in patients with MVO.
Limited data exist regarding polidocanol use for septal ablation, particularly in the context of midventricular obstruction (MVO) . This study presents the first reported use of polidocanol for septal ablation in patients with MVO.
Limited data exist regarding...
04/01/2025
Journal of Invasive Cardiology
Original Contribution
Heart Rate Variability of Interventional Cardiology Fellows and Attendings and Changes Over Time
04/01/2025
The study examined the stress levels of interventional cardiology (IC) fellows and attendings using both objective (heart rate variability) and subjective (State Trait Anxiety Inventory) metrics across the IC fellowship.
The study examined the stress levels of interventional cardiology (IC) fellows and attendings using both objective (heart rate variability) and subjective (State Trait Anxiety Inventory) metrics across the IC fellowship.
The study examined the stress...
04/01/2025
Journal of Invasive Cardiology
Intravascular Imaging
ECLIPSE Trial: Intravascular Imaging Can Improve Outcomes for Complex Stenting Procedures in Patients with High-Risk Calcified CAD
03/31/2025
“The ECLIPSE trial shows that use of intravascular imaging (IVI) to guide coronary stenting in severely calcified lesions prevents death, stent thrombosis, and unplanned repeat procedures in this high-risk patient population,” says first...
“The ECLIPSE trial shows that use of intravascular imaging (IVI) to guide coronary stenting in severely calcified lesions prevents death, stent thrombosis, and unplanned repeat procedures in this high-risk patient population,” says first...
“The ECLIPSE trial shows that...
03/31/2025
Cath Lab Digest
Aortic Stenosis
New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of Patients
03/31/2025
New data from DETECT AS and the EARLY TAVR Trial were presented at ACC.25 in Chicago, addressing the critical needs of patients with structural heart disease.
New data from DETECT AS and the EARLY TAVR Trial were presented at ACC.25 in Chicago, addressing the critical needs of patients with structural heart disease.
New data from DETECT AS and the...
03/31/2025
Cath Lab Digest
CAD in Women
New Intermountain Health Study Finds Gap Between Heart Disease Outcomes in Men and Women Has Narrowed Over Past 20 Years  
03/31/2025
Women studied tended to be older with more comorbidities (like high blood pressure, diabetes, and history of stroke and heart failure), have more stable chest pain, and experience less severe chest pain or heart attack when they came into the...
Women studied tended to be older with more comorbidities (like high blood pressure, diabetes, and history of stroke and heart failure), have more stable chest pain, and experience less severe chest pain or heart attack when they came into the...
Women studied tended to be older...
03/31/2025
Cath Lab Digest
AI
HeartFocus Clinical Trial Proves AI Can Empower Novices to Deliver Diagnostic-Quality Cardiac Ultrasounds
03/31/2025
Results showed that 100% of exams conducted by novices using HeartFocus met the diagnostic standards for all primary endpoints, with a strong correlation to expert-acquired scans across qualitative and quantitative assessments.
Results showed that 100% of exams conducted by novices using HeartFocus met the diagnostic standards for all primary endpoints, with a strong correlation to expert-acquired scans across qualitative and quantitative assessments.
Results showed that 100% of...
03/31/2025
Cath Lab Digest
plaque analysis
CONFIRM2 Registry: Late-Breaking Clinical Trial Results Demonstrate the Predictive Power of Cleerly's AI-QCT for Women’s Cardiovascular Risk at ACC.25
03/31/2025
The findings demonstrate that AI-QCT features of coronary artery disease (CAD), as detected by Cleerly’s AI-QCT, can identify women at high risk for major adverse cardiovascular events (MACE) and improves risk stratification - a population...
The findings demonstrate that AI-QCT features of coronary artery disease (CAD), as detected by Cleerly’s AI-QCT, can identify women at high risk for major adverse cardiovascular events (MACE) and improves risk stratification - a population...
The findings demonstrate that...
03/31/2025
Cath Lab Digest
Statins
CorCal Outcomes Study: Who Needs a Statin? Intermountain Study Compares Prescribing Recommendations Based on Traditional Risk Factors vs. Coronary Artery Calcium Scoring
03/31/2025
The research is part of CorCal Outcomes, a large, randomized clinical trial at Intermountain Health that is comparing the PCE versus CAC score guidance to initiate a statin prescription for patients for primary prevention of coronary heart...
The research is part of CorCal Outcomes, a large, randomized clinical trial at Intermountain Health that is comparing the PCE versus CAC score guidance to initiate a statin prescription for patients for primary prevention of coronary heart...
The research is part of CorCal...
03/31/2025
Cath Lab Digest

January 2006 Volume 18 Issue 1

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use